AbbVie Inc. (ETR:4AB)

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of EUR 334.51 billion. The enterprise value is 389.10 billion.

Market Cap	334.51B
Enterprise Value	389.10B

Important Dates

The last earnings date was Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	Oct 15, 2025

Share Statistics

Current Share Class	1.77B
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	73.91%
Float	1.76B

Valuation Ratios

The trailing PE ratio is 167.15 and the forward PE ratio is 16.01.

PE Ratio	167.15
Forward PE	16.01
PS Ratio	6.58
PB Ratio	-151.01
P/TBV Ratio	n/a
P/FCF Ratio	19.94
P/OCF Ratio	18.81
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.09, with an EV/FCF ratio of 23.19.

EV / Earnings	194.44
EV / Sales	7.55
EV / EBITDA	15.09
EV / EBIT	21.19
EV / FCF	23.19

Financial Position

The company has a current ratio of 0.72

Current Ratio	0.72
Quick Ratio	0.47
Debt / Equity	n/a
Debt / EBITDA	2.31
Debt / FCF	3.50
Interest Coverage	7.38

Financial Efficiency

Return on equity (ROE) is 137.96% and return on invested capital (ROIC) is 18.50%.

Return on Equity (ROE)	137.96%
Return on Assets (ROA)	9.59%
Return on Invested Capital (ROIC)	18.50%
Return on Capital Employed (ROCE)	22.50%
Revenue Per Employee	924,265
Profits Per Employee	36,385
Employee Count	55,000
Asset Turnover	0.43
Inventory Turnover	3.63

Taxes

Income Tax	-626.44M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.71% in the last 52 weeks. The beta is 0.51, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-1.71%
50-Day Moving Average	191.14
200-Day Moving Average	177.61
Relative Strength Index (RSI)	44.53
Average Volume (20 Days)	578

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.29

Income Statement

In the last 12 months, AbbVie had revenue of EUR 50.83 billion and earned 2.00 billion in profits. Earnings per share was 1.13.

Revenue	50.83B
Gross Profit	36.33B
Operating Income	18.12B
Pretax Income	1.41B
Net Income	2.00B
EBITDA	25.16B
EBIT	18.12B
Earnings Per Share (EPS)	1.13

Balance Sheet

The company has 4.83 billion in cash and 58.68 billion in debt, giving a net cash position of -53.85 billion.

Cash & Cash Equivalents	4.83B
Total Debt	58.68B
Net Cash	-53.85B
Net Cash Per Share	n/a
Equity (Book Value)	-2.22B
Book Value Per Share	-1.27
Working Capital	-9.25B

Cash Flow

In the last 12 months, operating cash flow was 17.78 billion and capital expenditures -1.00 billion, giving a free cash flow of 16.78 billion.

Operating Cash Flow	17.78B
Capital Expenditures	-1.00B
Free Cash Flow	16.78B
FCF Per Share	n/a

Margins

Gross margin is 71.46%, with operating and profit margins of 35.65% and 4.00%.

Gross Margin	71.46%
Operating Margin	35.65%
Pretax Margin	2.78%
Profit Margin	4.00%
EBITDA Margin	49.49%
EBIT Margin	35.65%
FCF Margin	33.00%

Dividends & Yields

This stock pays an annual dividend of 5.86, which amounts to a dividend yield of 3.10%.

Dividend Per Share	5.86
Dividend Yield	3.10%
Dividend Growth (YoY)	2.64%
Years of Dividend Growth	6
Payout Ratio	520.25%
Buyback Yield	-0.01%
Shareholder Yield	3.08%
Earnings Yield	0.60%
FCF Yield	5.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.21 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.21
Piotroski F-Score	7